Dermata net loss widens to USD 2,97 juta in Q2 FY26

Reuters2026/08/11 20:08

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Dermata Therapeutics membukukan rugi bersih USD 2,97 juta pada kuartal II, melebar dari USD 1,7 juta setahun sebelumnya.
Rugi per saham menyempit ke USD 0,74 dari USD 1,66, sementara rugi operasional melebar ke USD 3,01 juta dari USD 1,77 juta.
Beban R&D turun ke USD 213.000 dari USD 618.000, sedangkan SG&A melonjak ke USD 2,8 juta dari USD 1,16 juta.
Kas dan setara kas turun ke USD 4,41 juta per 30 Juni dari USD 7,52 juta akhir 2025; perseroan memperkirakan cukup hingga kuartal IV 2026.
Peluncuran produk DTC pertama, Tome Foundational Treatment, ditargetkan 25 Agustus 2026; manufaktur dan pengemasan telah rampung.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dermata Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608111605ACCESSWRNAPR_____1205950) on August 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Dermata net loss widens to USD 2,97 juta in Q2 FY26

You may also like

Crypto prices